The store will not work correctly when cookies are disabled.
Cookie Policy:This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Highly selective metastasis inhibitor in vitro. Binds to and stabilizes Cdc37-HSP90β heterocomplexes, consequently blocking its function and inhibiting cancer cell motility.
Does not bind to Cdc37 or HSP90β alone.
Inhibits cancer metastasis in vivo in murine models of human prostate and breast cancer.
Shown to exhibit a complete lack of cellular cytotoxicity and systemic toxicity.
Product References
Precision therapeutic targeting of human cancer cell motility: L. Xu, et al.; Nat. Commun. 9, 2454 (2018)